1. Seamless care, do it well or not at all

   • J. W. Foppe van Mil

   Editorial 21 November 2019 Pages: 1391 - 1393

2. Prescriptome analytics: an opportunity for clinical pharmacy

   • Pascal A. Le Corre

   Commentary 17 September 2019 Pages: 1394 - 1397

   

3. Treatment of nosocomial infections in intensive care unit with colistin and polymyxin B

   • Anahid Nourian
   • Mona Kargar

   Letter to the Editor 24 October 2019 Pages: 1398 - 1399

4. A systematic review of pharmacists’ interventions to support medicines optimisation in patients with visual impairment

   • Basma Y. Kentab
   • Heather E. Barry
   • Carmel M. Hughes

   Review Article Open access 17 September 2019 Pages: 1400 - 1407

   

5. Tigecycline-induced coagulopathy: a literature review

   • Nannan Cui
   • Hongliu Cai
   • Anwei Lu

   Review Article Open access 11 November 2019 Pages: 1408 - 1413

6. Association between EPHX1 polymorphisms and carbamazepine metabolism in epilepsy: a meta-analysis

   • Gui-Xin Zhao
   • Ming-Li Shen
   • Gong-Hao He

   Review Article 24 October 2019 Pages: 1414 - 1428

   

7. Prevalence of potential drug–drug interactions in outpatients on treatment with parenteral antineoplastic drugs

   • M. Castro-Manzanares
   • F. do Pazo-Oubiña
   • R. M. Rodríguez-Rincón

   Short Research Report 20 September 2019 Pages: 1429 - 1433

8. Utilization of oral anticoagulants in Korean nonvalvular atrial fibrillation patients

   • Hye-Yoon Song
   • Kyung-Bok Son
   • SeungJin Bae

   Research Article 14 September 2019 Pages: 1434 - 1441

   

9. Risk factors and prevention for perioperative anaphylaxis: a nested case-control study

   • Wanting Huang
   • Xinyu Li
   • Shenyin Zhu

   Research Article 17 September 2019 Pages: 1442 - 1450

   

10. Pharmacists’ experiences and perceptions about simulation use for learning and development of clinical skills in Kuwait

    • Maram Gamal Katoue
    • Jean Ker

    Research Article 28 September 2019 Pages: 1451 - 1461

    

11. Management of uncomplicated gastric ulcer in community pharmacy: a pseudo-patient study

    • Segun J. Showande
    • Adenike R. Adelakun

    Research Article 16 September 2019 Pages: 1462 - 1470

12. Community pharmacists’ clinical reasoning: a protocol analysis

    • Mohammad B. Nusair
    • M. Ken Cor
    • Lisa M. Guirguis

    Research Article 20 September 2019 Pages: 1471 - 1482

    

13. Assessing risk of adverse drug reactions in the elderly: a feasibility study

    • Andrew Ridge
    • Kate Macintyre
    • Luke Bereznicki

    Research Article 28 September 2019 Pages: 1483 - 1490

14. Integrating a pharmacist into an anaesthesiology and critical care department: Is this worthwhile?

    • C. Chapuis
    • P. Albaladejo
    • J. F. Payen

    Research Article 08 October 2019 Pages: 1491 - 1498

    

15. Trends in dispensing oral emergency contraceptives and safety issues: a survey of German community pharmacists

    • André Said
    • Matthias Ganso
    • Martin Schulz

    Research Article Open access 28 September 2019 Pages: 1499 - 1506

16. Drug-related problems among hospitalized patients with COPD in mainland China

    • Qin Li
    • Hui Jun Qu
    • Yun Liao

    Research Article Open access 08 November 2019 Pages: 1507 - 1515

    

17. Interdisciplinary medication review to improve pharmacotherapy for patients with intellectual disabilities

    • Anne Gerd Granas
    • Kjell Hermann Halvorsen
    • Cecilie Johannessen Landmark

    Research Article 15 November 2019 Pages: 1516 - 1525

    

18. Outpatient benzodiazepine utilization in Croatia: drug use or misuse

    • Marija Delaš Aždajić
    • Robert Likić
    • Danijela Štimac Grbić

    Research Article 08 October 2019 Pages: 1526 - 1535

    

19. Mortality risk in atrial fibrillation: the role of aspirin, vitamin K and non-vitamin K antagonists

    • Emilie Gieling
    • Frank de Vries
    • Andrea Burden

    Research Article Open access 08 October 2019 Pages: 1536 - 1544

    

20. Measure of adherence to direct-acting antivirals as a predictor of the effectiveness of hepatitis C treatment

    • María Ángeles Campos Fernández de Sevilla
    • Marta Gallego Úbeda
    • Irene Iglesias-Peinado

    Research Article 24 October 2019 Pages: 1545 - 1554

    

21. The role of the clinical pharmacist in the prevention of potential drug interactions in geriatric heart failure patients

    • Kaloyan D. Georgiev
    • Nadezhda Hvarchanova
    • Branimir Kanazirev

    Research Article 08 October 2019 Pages: 1555 - 1561

22. Patients’ clinical information requirements to apply the STOPP/START criteria

    • Rosário Carvalho
    • Marta Lavrador
    • M. Margarida Castel-Branco

    Research Article 29 October 2019 Pages: 1562 - 1569

23. Identification and resolution of drug-related problems in a tertiary hospital respiratory unit in China

    • Yulin Zhu
    • Cheng Liu
    • Feng Zhang

    Research Article Open access 25 October 2019 Pages: 1570 - 1577

24. Medicines prescription patterns in European neonatal units

    • Inge Mesek
    • Georgi Nellis
    • Irja Lutsar

    Research Article 17 October 2019 Pages: 1578 - 1591

    

25. Evaluation of a pharmacist-led antimicrobial stewardship service in a pediatric emergency department

    • K. M. MacMillan
    • M. MacInnis
    • E. K. Black

    Research Article 24 October 2019 Pages: 1592 - 1598

    

26. Preventability analysis of adverse drug reactions in a Jordanian hospital: a prospective observational study

    • Lama Al Damen
    • Iman Basheti

    Research Article 25 October 2019 Pages: 1599 - 1610

    

27. Antibiotic de-escalation therapy in patients with community-acquired nonbacteremic pneumococcal pneumonia

    • Atsushi Uda
    • Issei Tokimatsu
    • Ikuko Yano

    Research Article 25 October 2019 Pages: 1611 - 1617

28. The impact of an emergency medicine clinical pharmacist on nursing satisfaction

    • Cierra N. Treu
    • Janine L. Llamzon
    • Jeffrey D. Lazar

    Research Article 31 October 2019 Pages: 1618 - 1624

29. Patient adherence to rivaroxaban in deep vein thrombosis, a cohort study in Switzerland: quantitative results

    • Jennifer Dotta-Celio
    • Adriano Alatri
    • Lucia Mazzolai

    Research Article Open access 28 November 2019 Pages: 1625 - 1633

    

30. Snapshot of proton pump inhibitors prescriptions in a tertiary care hospital in Switzerland: less is more?

    • Camille Lenoir
    • Myriam El Biali
    • Victoria Rollason

    Research Article Open access 29 October 2019 Pages: 1634 - 1641

    

31. The hidden magnitude of polypharmacy: using defined daily doses and maximum licensed daily doses to measure antipsychotic load

    • My Linh Nguyen
    • Bruce Sunderland
    • Leanne Chalmers

    Research Article 01 November 2019 Pages: 1642 - 1651

    

32. Effect of clinical pharmacist intervention on the treatment of acute pancreatitis

    • Jia-Li Niu
    • Yun-Long Ding
    • Guang-Yu Zhao

    Research Article 07 November 2019 Pages: 1652 - 1657

33. Economic impact of Patient’s Own Medication use during hospitalisation: a multicentre pre-post implementation study

    • Loes J. M. van Herpen-Meeuwissen
    • Bart J. F. van den Bemt
    • Hein A. W. van Onzenoort

    Research Article Open access 08 November 2019 Pages: 1658 - 1665